Interpretation of the NCCN esophageal and esophagogastric junction cancers clinical practice guidelines in oncology (version 3. 2022)
- VernacularTitle:2022年V3版《NCCN食管和食管胃结合部癌临床实践指南》更新解读
- Author:
Gang JI
1
,
2
;
Jiangpeng WEI
1
,
2
;
Qiang LU
3
,
4
,
5
Author Information
1. Department of Digestive Surgery, Xijing Hospital, Air Force Military Medical University, Xi'
2. an, 710032, P. R. China
3. Department of Thoracic Surgery, Tangdu Hospital,
4. Air Force Military Medical University, Xi'
5. an, 710038, P. R. China
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
esophagogastric junction cancer;
National Comprehensive Cancer Network;
guideline interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(11):1414-1423
- CountryChina
- Language:Chinese
-
Abstract:
The National Comprehensive Cancer Network (NCCN) has updated and released the NCCN esophageal and esophagogastric junction cancers clinical practice guidelines in oncology (version 3. 2022). Compared with the version 4 of the guidelines in 2021, the 3 versions in 2022 have some updates and revisions, mainly focusing on molecular marker detection, perioperative treatment, advanced immunotherapy, radiotherapy and other aspects. This article will interpret the main content of the new edition of the guidelines, in order to enhance the understanding of the guidelines and guide the clinical practice of diagnosis and treatment.
